Regulatory Affairs: The IND, NDA, and Post-Marketing

Attend this virtual training course to learn about FDA regulations and expectations for the content, submission and review of INDs and NDAs, and the importance of regulatory strategy.

Volver a Agenda

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

Session Chair(s)

Elliott Berger, PHD, MS

President

ETB Regulatory Consulting, United States

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

¿Tiene una cuenta?

Regulatory Affairs: The IND, NDA, and Post-Marketing

Introduction to Regulation of Drugs and Biologics in the United States: Pre-Course Part One

Session Chair(s)

Elliott Berger, PHD, MS

Be informed and stay engaged.